All Work

Chris Lange

Oncolytics Newest Orphan Drug Designation

ThinkstockOncolytics Biotech Inc. (NASDAQ: ONCY) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug designation for Reolysin. Reolysin is the company’s lead product candidate that is designated for the treatment of…

Chris Lange · 12 years ago

Are Mylan Earnings Enough?

ThinkstockMonday after the markets closed, Mylan, Inc. (NASDAQ: MYL) reported its fourth-quarter financial results as in line with estimates. Specifically the company had $1.05 in earnings per share (EPS) and $2.08 billion in revenue…

Chris Lange · 12 years ago

Is American Realty Back?

Before the markets opened Monday morning, American Realty Capital Properties restated operating results for its third quarter in 2014.

Chris Lange · 12 years ago

7 Top Earnings Previews for the Week Ahead

24/7 Wall St. has put together a preview of some of the larger companies reporting in the first week of March, including Include Staples, Costco and Kroger.

Chris Lange · 12 years ago